Loading clinical trials...
Loading clinical trials...
A Phase II Study of Weekly 24-hour Infusion 5-fluoro-deoxyuridine (FUdR)/Leucovorin With Oxaliplatin and Docetaxel (Taxotere) as First-line Treatment in Patients With Metastatic Gastric Adenocarcinoma (IIT# 14065)
Conditions
Interventions
Docetaxel
Floxuridine
+2 more
Locations
1
United States
University of Miami Sylvester Comprehensive Cancer Center - Miami
Miami, Florida, United States
Start Date
June 1, 2005
Primary Completion Date
December 1, 2009
Completion Date
March 1, 2010
Last Updated
February 7, 2017
NCT04550494
NCT04704661
NCT05489211
NCT05702229
NCT04674267
NCT07217704
Lead Sponsor
University of Miami
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions